Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 37.00
+2.75 (8.03%)
May 13, 2025, 2:45 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 18.61 billion as of May 12, 2025. Its market cap has increased by 144.99% in one year.
Market Cap
18.61B
Enterprise Value
21.63B
Revenue
6.09B
Ranking
n/a
PE Ratio
21.32
Stock Price
37.00
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has decreased from 26.66B to 18.61B, a decrease of -30.18%. That is a compound annual growth rate of -6.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 117.99B |
| WuXi Biologics | 93.82B |
| Innovent Biologics | 86.36B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |